These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17598435)

  • 61. [Stability and/or variability of the expression of genetic polymorphism of hydroxylation and acetylation in patients with various pathologies and under various treatments].
    Bechtel P; Joanne C; Bechtel Y; Grandmottet M; Jounet JM
    Ann Biol Clin (Paris); 1986; 44(4):361-7. PubMed ID: 3538951
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
    Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
    Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease.
    Thomas P; O' Callaghan NJ; Fenech M
    Mech Ageing Dev; 2008 Apr; 129(4):183-90. PubMed ID: 18242664
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Investigation of the role of the dopamine transporter in susceptibility to behavioural and psychological symptoms of patients with probable Alzheimer's disease.
    Pritchard AL; Pritchard CW; Bentham P; Lendon CL
    Dement Geriatr Cogn Disord; 2008; 26(3):257-60. PubMed ID: 18841010
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Acetylation of sulfadimezine and ethazole in rats].
    Krylov IuF; Lil'in ET; Vaniukov MM; Monastyrskaia AR; Isaeva IV
    Farmakol Toksikol; 1982; 45(4):85-8. PubMed ID: 7128797
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sparteine oxidation polymorphism in Denmark.
    Brøsen K; Otton SV; Gram LF
    Acta Pharmacol Toxicol (Copenh); 1985 Nov; 57(5):357-60. PubMed ID: 4090995
    [TBL] [Abstract][Full Text] [Related]  

  • 68. N-acetylation and debrisoquine type oxidation polymorphism in Caucasians--with reference to age and sex.
    Siegmund W; Hanke W; Zschiesche M; Franke G; Biebler KE; Wilke A
    Int J Clin Pharmacol Ther Toxicol; 1990 Dec; 28(12):504-9. PubMed ID: 2086491
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interleukin-1alpha -889 C/T polymorphism in Turkish patients with late-onset Alzheimer's disease.
    Dursun E; Gezen-Ak D; Ertan T; Bilgiç B; Gürvit H; Emre M; Eker E; Engin F; Uysal O; Yilmazer S
    Dement Geriatr Cogn Disord; 2009; 27(1):82-7. PubMed ID: 19155622
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evidence for polymorphic oxidation of sparteine in Japanese subjects.
    Ishizaki T; Eichelbaum M; Horai Y; Hashimoto K; Chiba K; Dengler HJ
    Br J Clin Pharmacol; 1987 Apr; 23(4):482-5. PubMed ID: 3580254
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pantothenic acid, acute ethanol consumption and sulphadimidine acetylation.
    Vas A; Gachályi B; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1990 Mar; 28(3):111-4. PubMed ID: 2318546
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [The genetically determined polymorphism of metabolic oxidation of the sparteine-debrisoquin type].
    Piotrovskiĭ VK; Belolipetskaia VG
    Farmakol Toksikol; 1991; 54(6):60-6. PubMed ID: 1804700
    [No Abstract]   [Full Text] [Related]  

  • 73. The relationship between paroxetine and the sparteine oxidation polymorphism.
    Sindrup SH; Brøsen K; Gram LF; Hallas J; Skjelbo E; Allen A; Allen GD; Cooper SM; Mellows G; Tasker TC
    Clin Pharmacol Ther; 1992 Mar; 51(3):278-87. PubMed ID: 1531950
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stress and coping in older people with Alzheimer's disease.
    de Souza-Talarico JN; Chaves EC; Nitrini R; Caramelli P
    J Clin Nurs; 2009 Feb; 18(3):457-65. PubMed ID: 19077019
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sparteine oxidation polymorphism: a family study.
    Brøsen K; Otton SV; Gram LF
    Br J Clin Pharmacol; 1986 Jun; 21(6):661-7. PubMed ID: 3741716
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Acetylation phenotype in patients with periodic disease].
    Podymov VK; Vinogradova OM; Kovaleva VL; Kochubeĭ LN; Galstian SM
    Ter Arkh; 1988; 60(6):95-8. PubMed ID: 3206381
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The neural correlates of verbal short-term memory in Alzheimer's disease: an fMRI study.
    Peters F; Collette F; Degueldre C; Sterpenich V; Majerus S; Salmon E
    Brain; 2009 Jul; 132(Pt 7):1833-46. PubMed ID: 19433442
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Short arm of chromosome 11 and sporadic Alzheimer's disease: catalase and cathepsin D gene polymorphisms.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Bifaro L; Menga R; Santamato A; Seripa D; Pilotto A; Capurso A; Panza F
    Neurosci Lett; 2008 Feb; 432(3):237-42. PubMed ID: 18248894
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of arginine-nitric oxide pathway in patients with Alzheimer disease.
    Vural H; Sirin B; Yilmaz N; Eren I; Delibas N
    Biol Trace Elem Res; 2009; 129(1-3):58-64. PubMed ID: 19099206
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 2008 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2008 Mar; 4(2):110-33. PubMed ID: 18631956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.